Anti-WDR13/ MG21 monoclonal antibody

Anti-WDR13/ MG21 antibody for FACS & in-vivo assay

Target products collectionGo to WDR13/WDR13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1932-Ab-1/ GM-Tg-hg-MP1932-Ab-2Anti-Human WDR13 monoclonal antibodyHuman
GM-Tg-rg-MP1932-Ab-1/ GM-Tg-rg-MP1932-Ab-2Anti-Rat WDR13 monoclonal antibodyRat
GM-Tg-mg-MP1932-Ab-1/ GM-Tg-mg-MP1932-Ab-2Anti-Mouse WDR13 monoclonal antibodyMouse
GM-Tg-cynog-MP1932-Ab-1/ GM-Tg-cynog-MP1932-Ab-2Anti-Cynomolgus/ Rhesus macaque WDR13 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1932-Ab-1/ GM-Tg-felg-MP1932-Ab-2Anti-Feline WDR13 monoclonal antibodyFeline
GM-Tg-cang-MP1932-Ab-1/ GM-Tg-cang-MP1932-Ab-2Anti-Canine WDR13 monoclonal antibodyCanine
GM-Tg-bovg-MP1932-Ab-1/ GM-Tg-bovg-MP1932-Ab-2Anti-Bovine WDR13 monoclonal antibodyBovine
GM-Tg-equg-MP1932-Ab-1/ GM-Tg-equg-MP1932-Ab-2Anti-Equine WDR13 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1932-Ab-1/ GM-Tg-hg-MP1932-Ab-2; GM-Tg-rg-MP1932-Ab-1/ GM-Tg-rg-MP1932-Ab-2;
GM-Tg-mg-MP1932-Ab-1/ GM-Tg-mg-MP1932-Ab-2; GM-Tg-cynog-MP1932-Ab-1/ GM-Tg-cynog-MP1932-Ab-2;
GM-Tg-felg-MP1932-Ab-1/ GM-Tg-felg-MP1932-Ab-2; GM-Tg-cang-MP1932-Ab-1/ GM-Tg-cang-MP1932-Ab-2;
GM-Tg-bovg-MP1932-Ab-1/ GM-Tg-bovg-MP1932-Ab-2; GM-Tg-equg-MP1932-Ab-1/ GM-Tg-equg-MP1932-Ab-2
Products NameAnti-WDR13 monoclonal antibody
Formatmab
Target NameWDR13
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-WDR13 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species WDR13/ MG21 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1932
    Target NameWDR13
    Gene ID64743,73447,317370,100424147,480904,101095316,523881,100062003
    Gene Symbol and Synonyms1700060B08Rik,5730411P10Rik,DXHXS7467e,MG21,mMg21,RGD1560982,WDR13
    Uniprot AccessionQ9H1Z4
    Uniprot Entry NameWDR13_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000101940
    Target ClassificationN/A

    The target: WDR13, gene name: WDR13, also named as MG21. This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by Gly-His and Trp-Asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. A similar protein in mouse is thought to be a negative regulator of the pancreatic beta cell proliferation. Mice lacking this gene exhibit increased pancreatic islet mass and higher serum insulin levels, and are mildly obese. [provided by RefSeq, Nov 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.